Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erika Vacchelli

Showing results (21-30 of 90) with videos related to

Pageof 9
Sort By:
Oncoimmunology|March 27, 2023
Rs867228 in FPR1 accelerates the manifestation of luminal B breast cancerVincent Carbonnier, Julie Le Naour, Thomas Bachelot, et al.
Seminars in Cancer Biology|June 4, 2013
Regulation of autophagy by stress-responsive transcription factorsFederico Pietrocola, Valentina Izzo, Mireia Niso-Santano, et al.
Oncoimmunology|June 22, 2012
Trial watch: Chemotherapy with immunogenic cell death inducersErika Vacchelli, Lorenzo Galluzzi, Wolf Hervé Fridman, et al.
Oncoimmunology|March 26, 2013
Trial watch: Cardiac glycosides and cancer therapyLaurie Menger, Erika Vacchelli, Oliver Kepp, et al.
Oncoimmunology|January 25, 2021
A major genetic accelerator of cancer diagnosis: rs867228 in FPR1Zsofia Sztupinszki, Julie Le Naour, Erika Vacchelli, et al.
Oncoimmunology|June 14, 2013
Trial Watch: Adoptive cell transfer for anticancer immunotherapyErika Vacchelli, Alexander Eggermont, Wolf Hervé Fridman, et al.
Oncoimmunology|March 8, 2014
Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapyErika Vacchelli, Fernando Aranda, Alexander Eggermont, et al.
Oncoimmunology|July 30, 2016
Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancerElisa E Baracco, Federico Pietrocola, Aitziber Buqué, et al.
Oncoimmunology|April 5, 2014
Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapyFernando Aranda, Erika Vacchelli, Alexander Eggermont, et al.
Oncoimmunology|May 21, 2013
Trial watch: Chemotherapy with immunogenic cell death inducersErika Vacchelli, Laura Senovilla, Alexander Eggermont, et al.
Pageof 9

Showing results (21-30 of 90) with videos related to

Sort By:
Pageof 9
Oncoimmunology|March 27, 2023
Rs867228 in FPR1 accelerates the manifestation of luminal B breast cancerVincent Carbonnier, Julie Le Naour, Thomas Bachelot, et al.
Seminars in Cancer Biology|June 4, 2013
Regulation of autophagy by stress-responsive transcription factorsFederico Pietrocola, Valentina Izzo, Mireia Niso-Santano, et al.
Oncoimmunology|June 22, 2012
Trial watch: Chemotherapy with immunogenic cell death inducersErika Vacchelli, Lorenzo Galluzzi, Wolf Hervé Fridman, et al.
Oncoimmunology|March 26, 2013
Trial watch: Cardiac glycosides and cancer therapyLaurie Menger, Erika Vacchelli, Oliver Kepp, et al.
Oncoimmunology|January 25, 2021
A major genetic accelerator of cancer diagnosis: rs867228 in FPR1Zsofia Sztupinszki, Julie Le Naour, Erika Vacchelli, et al.
Oncoimmunology|June 14, 2013
Trial Watch: Adoptive cell transfer for anticancer immunotherapyErika Vacchelli, Alexander Eggermont, Wolf Hervé Fridman, et al.
Oncoimmunology|March 8, 2014
Trial Watch: Tumor-targeting monoclonal antibodies in cancer therapyErika Vacchelli, Fernando Aranda, Alexander Eggermont, et al.
Oncoimmunology|July 30, 2016
Inhibition of formyl peptide receptor 1 reduces the efficacy of anticancer chemotherapy against carcinogen-induced breast cancerElisa E Baracco, Federico Pietrocola, Aitziber Buqué, et al.
Oncoimmunology|April 5, 2014
Trial Watch: Immunostimulatory monoclonal antibodies in cancer therapyFernando Aranda, Erika Vacchelli, Alexander Eggermont, et al.
Oncoimmunology|May 21, 2013
Trial watch: Chemotherapy with immunogenic cell death inducersErika Vacchelli, Laura Senovilla, Alexander Eggermont, et al.
Pageof 9